Exchange: NYSEMkt·Updated 04:10 PM EDT
APUS logo

APUS Apimeds Pharmaceuticals US Inc.

$3.87
$0.08
(2.02%)
Today
Closed $3.87
$0.00
(0.00%)
After Hours
Mkt Cap$5.84M
Vol9,073.00

About APUS

Apimeds Pharmaceuticals US, Inc. is a clinical stage biopharmaceutical company that engages in the development of Apitox, an intradermally administered bee venom-based toxin. It primarily focuses on developing innovative therapies for inflammation and pain management in knee osteoarthritis (OA) and, to a lesser extent, multiple sclerosis (MS). The company was founded on May 11, 2020 and is headquartered in Matawan, NJ.
49

Neutral Sentiment

How do you feel about APUS?

Advertisement|Remove ads.